Weak quarterly, Ralph has some explaining to do regarding operating expenses blowing out. Interested to hear what he has to say regarding organ of a chip and zoetis partnership. Not a fan of the revenue range reduction in the high end. Cannot help but feel that the language used is not as bullish as it has been of late.
punished. all imo